Overview
It is an observational, non-interventional, prospective, monocentric study, whose objective is to enroll 1500 patients with lymphoma in 5 years within the Institute of Hematology "Seragnoli".
Description
The study is aimed at enriching the data on the prognostic role of genetic and epidemiological factors associated with clinical and epidemiological data of patients; to identify factors that influence the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment; to document the impact of the disease on quality of life and to provide a platform for future research projects.
Study-specific questionnaires will be administered to patients, both at baseline and during follow-up, which methodologically represent a useful tool in order to achieve these objectives.
Eligibility
Inclusion Criteria:
- Age greater than or equal to 18 years at enrollment
- Diagnosis of lymphoma within 3 months of enrollment
- Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment
- Signing of the informed consent form
Exclusion Criteria:
- none